Skip to main content Skip to navigation

Research Exchange

VDX-111: A novel targeted therapeutic for triple-negative breast cancer

Type

grant

Grant Number

R44 CA250674

A global leader in the fight against gynecologic cancer

LIVING LAB

Join the Living Lab Our Team Governance & Ethics Shareable Resources

DISCOVERY LAB

Discovery Lab How It Works Upcoming Webinars Contribute Data

ABOUT

About OCRA Get Involved Make a Donation Contact Us

© 2025 Ovarian Cancer Research Alliance, Inc.

Privacy Terms Accessibility

VDX-111: A novel targeted therapeutic for triple-negative breast cancer